Clinical Trial Update: A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia. [Phase 3]

View source ↗

Summary

Phase 3 trial results detailing the long-term safety and tolerability of an investigational drug in adults with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Investigational Drug (name undisclosed)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2025-12-31